Suppr超能文献

手术治疗双侧肾脏肿块且随访时间至少 10 年的患者的结果。

Outcomes of patients with surgically treated bilateral renal masses and a minimum of 10 years of followup.

机构信息

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

出版信息

J Urol. 2012 Dec;188(6):2084-8. doi: 10.1016/j.juro.2012.08.038. Epub 2012 Oct 18.

Abstract

PURPOSE

Nephron sparing surgery has been advocated for patients with bilateral renal masses but long-term functional and oncological outcomes are lacking. We report the outcomes of patients with bilateral renal masses and a minimum 10-year followup.

MATERIALS AND METHODS

Patients with bilateral renal masses evaluated at our institution who were treated with initial surgery at least 10 years ago and underwent interventions on each renal unit were included in the analysis. Collected data included demographics, hereditary diagnosis, number of renal interventions, renal function and mortality status. Overall and renal cell carcinoma specific survival was assessed. Comparisons were made of renal function and overall survival between groups with 2 renal units and a surgically solitary kidney.

RESULTS

A total of 128 patients met study inclusion criteria. Median followup in our cohort was 16 years (mean 17, range 10 to 49). The median number of surgical interventions was 3 (range 2 to 10). Of the patients 87 (68%) required repeat interventions on the ipsilateral renal unit at last followup with a median of 6.2 years (range 0.7 to 21) between interventions. Overall and renal cell cancer specific survival was 88% and 97%, respectively. Six patients (4.7%) ultimately underwent bilateral nephrectomy. Although renal function was better preserved in patients with 2 kidneys (70 vs 53 ml/minute/1.73 m(2), p = 0.0002), there was no difference in overall survival between those with bilateral kidneys or a surgically solitary kidney.

CONCLUSIONS

At a minimum 10-year followup after initial surgery, nephron sparing surgery allowed for excellent oncological and functional outcomes. Despite the need for repeat surgical interventions, nephron sparing surgery enabled dialysis to be avoided in more than 95% of patients.

摘要

目的

保肾手术已被提倡用于双侧肾脏肿块患者,但缺乏长期的功能和肿瘤学结果。我们报告了至少有 10 年随访的双侧肾脏肿块患者的结果。

材料和方法

本研究纳入了在我们机构接受评估的双侧肾脏肿块患者,这些患者在至少 10 年前接受了初始手术治疗,并且对每个肾脏单位进行了干预。收集的数据包括人口统计学、遗传性诊断、肾脏干预次数、肾功能和死亡率。评估了总体生存率和肾细胞癌特异性生存率。比较了两组患者的肾功能和总体生存率,两组患者分别为两个肾脏单位和手术孤立肾脏。

结果

共有 128 名患者符合研究纳入标准。本队列的中位随访时间为 16 年(平均 17 岁,范围 10 至 49 岁)。中位手术干预次数为 3 次(范围 2 至 10 次)。在最后一次随访时,87 名患者(68%)需要对同侧肾脏单位进行重复干预,两次干预之间的中位时间为 6.2 年(范围 0.7 至 21 年)。总体生存率和肾细胞癌特异性生存率分别为 88%和 97%。最终有 6 名患者(4.7%)接受了双侧肾切除术。尽管双侧肾脏患者的肾功能保存更好(70 与 53ml/min/1.73m2,p=0.0002),但双侧肾脏或手术孤立肾脏患者的总体生存率无差异。

结论

在初始手术后至少 10 年的随访中,保肾手术可获得良好的肿瘤学和功能结果。尽管需要重复手术干预,但保肾手术使超过 95%的患者避免了透析。

相似文献

1
Outcomes of patients with surgically treated bilateral renal masses and a minimum of 10 years of followup.
J Urol. 2012 Dec;188(6):2084-8. doi: 10.1016/j.juro.2012.08.038. Epub 2012 Oct 18.
2
Renal function outcomes in patients treated with nephron sparing surgery for bilateral Wilms tumor.
J Urol. 2007 Oct;178(4 Pt 2):1786-9; discussion 1789-90. doi: 10.1016/j.juro.2007.03.183. Epub 2007 Aug 17.
3
4
Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes.
J Urol. 2010 May;183(5):1719-24. doi: 10.1016/j.juro.2010.01.010. Epub 2010 Mar 17.
6
Renal function and oncologic outcomes in nephron sparing surgery for renal masses in solitary kidneys.
World J Urol. 2011 Jun;29(3):343-8. doi: 10.1007/s00345-010-0576-9. Epub 2010 Jul 11.
7
Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
Scand J Urol Nephrol. 2007;41(1):10-3. doi: 10.1080/00365590600911225.
8
Minimally invasive nephron sparing management for renal tumors in solitary kidneys.
J Urol. 2009 Nov;182(5):2150-7. doi: 10.1016/j.juro.2009.07.066. Epub 2009 Sep 16.
10
The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma.
J Urol. 2006 Nov;176(5):1990-5; discussion 1995. doi: 10.1016/j.juro.2006.07.015.

引用本文的文献

1
Outcomes of and indications for renal transplantation in patients with von Hippel Lindau disease.
Urol Oncol. 2023 Dec;41(12):487.e1-487.e6. doi: 10.1016/j.urolonc.2023.09.003. Epub 2023 Sep 29.
2
A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer.
Urol Oncol. 2021 Sep;39(9):548-560. doi: 10.1016/j.urolonc.2021.04.038. Epub 2021 Jun 4.
3
Evaluation of functional outcome of bilateral kidney tumors after sequential surgery.
BMC Cancer. 2021 May 24;21(1):592. doi: 10.1186/s12885-021-08324-3.
5
Surgical Insights for the Management of Variant Histology in Renal Cell Carcinoma.
Int Braz J Urol. 2021 Sep-Oct;47(5):935-942. doi: 10.1590/S1677-5538.IBJU.2020.0778.
6
NCCN Guidelines Insights: Kidney Cancer, Version 1.2021.
J Natl Compr Canc Netw. 2020 Sep;18(9):1160-1170. doi: 10.6004/jnccn.2020.0043.
7
Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights.
Eur Urol. 2019 Dec;76(6):754-764. doi: 10.1016/j.eururo.2019.06.015. Epub 2019 Jul 18.
10
Implications of Von Hippel-Lindau Syndrome and Renal Cell Carcinoma.
J Kidney Cancer VHL. 2015 Sep 25;2(4):163-173. doi: 10.15586/jkcvhl.2015.41. eCollection 2015.

本文引用的文献

1
Impact of genetics on the diagnosis and treatment of renal cancer.
Curr Urol Rep. 2011 Feb;12(1):47-55. doi: 10.1007/s11934-010-0156-y.
2
Feasibility and outcomes of partial nephrectomy for resection of at least 20 tumors in a single renal unit.
J Urol. 2011 Jan;185(1):49-53. doi: 10.1016/j.juro.2010.09.032. Epub 2010 Nov 12.
3
Surgical management of bilateral synchronous kidney tumors: functional and oncological outcomes.
J Urol. 2010 Sep;184(3):865-72; quiz 1235. doi: 10.1016/j.juro.2010.05.042.
4
Oncological outcomes of partial nephrectomy for multifocal renal cell carcinoma greater than 4 cm.
J Urol. 2010 Jul;184(1):59-63. doi: 10.1016/j.juro.2010.03.035. Epub 2010 May 15.
5
Long-term management of bilateral, multifocal, recurrent renal carcinoma.
Nat Rev Urol. 2010 May;7(5):267-75. doi: 10.1038/nrurol.2010.44.
6
Management of locally recurrent kidney cancer.
Curr Urol Rep. 2010 Feb;11(1):15-21. doi: 10.1007/s11934-009-0085-9.
7
Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes.
J Urol. 2010 May;183(5):1719-24. doi: 10.1016/j.juro.2010.01.010. Epub 2010 Mar 17.
8
Partial nephrectomy after previous radio frequency ablation: the National Cancer Institute experience.
J Urol. 2009 Nov;182(5):2158-63. doi: 10.1016/j.juro.2009.07.064. Epub 2009 Sep 16.
9
Guideline for management of the clinical T1 renal mass.
J Urol. 2009 Oct;182(4):1271-9. doi: 10.1016/j.juro.2009.07.004. Epub 2009 Aug 14.
10
The clinical implications of the genetics of renal cell carcinoma.
Urol Oncol. 2009 Mar-Apr;27(2):131-6. doi: 10.1016/j.urolonc.2008.11.001.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验